Search results
Novavax Seeks FDA Nod for Updated COVID-19 Vaccine - Novavax (NASDAQ:NVAX), Moderna (NASDAQ:MRNA)
Benzinga· 6 hours agoSubject to necessary permissions from the FDA and CDC, Novavax intends to market this updated...
3 Ultra-High-Yield Dividend Stocks Billionaires Are Sinking Their Teeth Into
Motley Fool via Yahoo Finance· 6 days agoThis makes the single-digit forward price-to-earnings (P/E) ratios and high-yields attached to...
Sarepta shares rise as Pfizer DMD trial misses goals By Investing.com
Investing.com· 5 days agoOn Thursday, Piper Sandler maintained an Overweight rating on Sarepta Therapeutics (NASDAQ:SRPT)...
Dividend stocks can help lower your risk. Many are bargains right now.
MarketWatch via Yahoo Finance· 6 days agoHD — the fund’s 10th largest U.S. stockholding — is another interesting example. If you bought the ...
3 High-Yield S&P 500 Dividend Stocks Down More Than 25% to Buy Now and Hold for at Least a Decade |...
The Motley Fool· 3 days agoThe S&P 500 is up an incredible 25% over the past 12 months, but not every stock in the benchmark...
These 3 Clinical-Stage Biotech Stocks Can Offer Exponential Gains | Investing.com
Investing.com· 4 days agoStocks Analysis by The Tokenist (Timothy Fries) covering: Pfizer Inc, Ocuphire Pharma Inc, Rocket...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 5 days agoBiotech stock hit a two-year high in February, but have trended sideways in the months since despite...
Pfizer (PFE) Phase III DMD Gene Therapy Study Misses Goal
Zacks· 6 days agoFree Report) announced that a phase III study on its mini-dystrophin gene therapy fordadistrogene movaparvovec for treating Duchenne muscular dystrophy (“DMD”) failed to meet the primary endpoint ...
Three’s a trend. Citi is the latest to bump S&P 500 target, but it sees opportunistic pullbacks...
Market Watch· 13 hours agoWall Street is placing more bets on a 5,600 finish for the S&P 500 this year, provided tech behaves.
Novavax (NVAX) Seeks FDA Nod for Updated COVID-19 Vaccine
Zacks via Yahoo Finance· 1 day agoNovavax (NVAX) seeks FDA???s approval to update its COVID-19 vaccine for the 2024-2025 fall season...